These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Cholesterol lowering. Should it continue to be the last thing we do? Waters D Circulation; 1999 Jun; 99(25):3215-7. PubMed ID: 10385491 [No Abstract] [Full Text] [Related]
63. Cholesterol and cardiovascular disease: current perspectives. Introduction and overview. Steinberg D Circulation; 1987 Sep; 76(3):502-3. PubMed ID: 3621515 [No Abstract] [Full Text] [Related]
64. Improvement in endothelial dysfunction with LDL cholesterol level < 80 mg/dl in type 2 diabetic patients. Sheu WH; Chen YT; Lee WJ Diabetes Care; 2001 Aug; 24(8):1499-501. PubMed ID: 11473096 [No Abstract] [Full Text] [Related]
65. National cholesterol education program (NCEP) guidelines too complex. Feeman WE Prev Cardiol; 2005; 8(3):188. PubMed ID: 16108130 [No Abstract] [Full Text] [Related]
67. What are the priorities for managing cholesterol effectively? Brown WV Am J Cardiol; 2001 Aug; 88(4A):21F-4F. PubMed ID: 11520483 [TBL] [Abstract][Full Text] [Related]
68. Serum cholesterol levels in Puerto Rican volunteer blood donors. Marcial MA; Fernández Carbia A Bol Asoc Med P R; 1989 Aug; 81(8):297-9. PubMed ID: 2765045 [TBL] [Abstract][Full Text] [Related]
69. Principal results of the Hypertension and Lipid Trial (HALT): a multicenter study of doxazosin in patients with hypertension. Levy D; Walmsley P; Levenstein M Am Heart J; 1996 May; 131(5):966-73. PubMed ID: 8615318 [TBL] [Abstract][Full Text] [Related]
70. Cholesterol: myth or reality? Thompson WG South Med J; 1990 Apr; 83(4):435-40. PubMed ID: 2181692 [No Abstract] [Full Text] [Related]
71. [Is hypolipemic treatment effective as a preventive measure?]. Rywik S Przegl Lek; 1989; 46(7):619-23. PubMed ID: 2685917 [No Abstract] [Full Text] [Related]
72. [Letter on the article: "Which lipid profiles and how to interpret in patients with coronary heart disease?"]. Ambrosi P Presse Med; 2010 Feb; 39(2):286-7. PubMed ID: 20074902 [No Abstract] [Full Text] [Related]
73. High-density lipoprotein cholesterol therapies: the next frontier in lipid management. Duffy D; Rader DJ J Cardiopulm Rehabil; 2006; 26(1):1-8. PubMed ID: 16617219 [TBL] [Abstract][Full Text] [Related]
74. [Evaluation of the indicators of arteriosclerosis risk factors: cholesterol:HDL cholesterol and LDL cholesterol: HDL cholesterol in acute and chronic diseases of the liver]. Simon K; Kowalewski W; Dobracki W Przegl Lek; 1987; 44(11):746-50. PubMed ID: 3447241 [No Abstract] [Full Text] [Related]
75. Hypercholesterolemia: a reversible risk factor for coronary heart disease. Mishkel MA CMAJ; 1989 Feb; 140(4):419. PubMed ID: 2644008 [No Abstract] [Full Text] [Related]
76. Reassessment of the value of lowering serum cholesterol. Questioning the wisdom of widespread intervention. Labreche DG Clin Pharm; 1988 Aug; 7(8):592-603. PubMed ID: 3048850 [No Abstract] [Full Text] [Related]